微创机器人 2021 年营业总收入 2.15 百万元，归母净利润-5.84 亿元。
收入主要来源于 2021 年 6 月获批的蜻蜓眼三维腹腔镜的销售，腔镜手术机器人 2022 年 1 月获批，预计 2026 年给公司带来 26 亿元收入。
销售费用 0.79 亿元，同比增长 2533%，助推产品商业化。
研发投入 3.93 亿元，持续新高，随着收入的增长，研发费用率将稳定下降。$MircroPort Medbot-B(02252.HK)
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments